Ketamine with a crisis plan for suicidal thoughts in the ER
Treatments studied
Part of Mental health clinical trials.
This study tests whether ketamine plus a structured crisis-response plan can help reduce suicidal thoughts for adults admitted from the ER. It also aims to make care in the emergency setting more consistent and effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re 18 to 70 years old and you’re in the ER for acute suicidal thoughts
- A hospital team decides you’ll be admitted to an inpatient psychiatric or stabilization unit before you consent
- You can read and write English and understand the study enough to consent yourself
- You’re not having severe confusion or uncontrolled symptoms like active psychosis, mania, or hallucinations
- You are not pregnant or breastfeeding, and you don’t have a known allergy to ketamine
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a single dose of ketamine can quickly reduce suicidal thoughts in people who come to the emergency department. If you are having active suicidal thoughts and need inpatient care, you may be able to join.
This study tests whether a single dose of ketamine, given by injection in the emergency department, combined with brief psychotherapy, can quickly reduce suicidal thoughts and keep you safe. It aims to find fast-acting relief for people in crisis, possibly helping you feel better sooner and reducing the risk of future attempts.
This study tests whether a single ketamine injection can quickly reduce suicidal thoughts in people waiting to be admitted to the psychiatric unit. Ketamine is a fast-acting medication that may help calm the mind during a crisis.
This study tests whether ketamine can help reduce suicidal thoughts in people with depression. It also looks at how ketamine affects a brain receptor that may be linked to mood and stress, to learn why it might help.
This study tests if ketamine can help reduce suicidal thoughts in people with major depression. You'll receive ketamine treatment and be monitored closely.
This Phase 3 study tests ketamine to reduce ongoing suicidal thoughts and help prevent another suicide attempt in youth after a recent attempt. It will compare ketamine treatment against standard care to see if it helps improve safety and reduce suicide risk.
Hear when a new Suicide trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.